We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+30.01%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$1.26B
Cap. Flow
+$1B
Cap. Flow %
37.09%
Top 10 Hldgs %
19.79%
Holding
1,149
New
553
Increased
136
Reduced
101
Closed
286

Sector Composition

Rank Sector Weight
1 Technology 1.4%
2 Communication Services 1.31%
3 Healthcare 1.14%
4 Consumer Discretionary 0.97%
5 Consumer Staples 0.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGF.A
1101
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-3,000
Closed -$22K
ITCI
1102
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-20,000
Closed -$513K
ITCI
1103
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-35,000
Closed -$898K
NKLA
1104
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
-3,583
Closed -$7.26M
EGIO
1105
DELISTED
Edgio, Inc. Common Stock
EGIO
-563
Closed -$141K
TWOU
1106
DELISTED
2U Inc
TWOU
-333
Closed -$380K
TWOU
1107
PUT
DELISTED
2U Inc
TWOU
-2,550
Closed -$2.9M
GOL
1108
PUT
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-10,000
Closed -$68K
ICPT
1109
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-6,500
Closed -$311K
ICPT
1110
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-1,000
Closed -$48K
TWNK
1111
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
-5,000
Closed -$61K
ZYNE
1112
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-185,000
Closed -$623K
ZYNE
1113
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-87,600
Closed -$295K
RETA
1114
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-12,500
Closed -$1.95M
IDEX
1115
CALL
DELISTED
Ideanomics, Inc. Common Stock
IDEX
-72
Closed -$18K
MAXR
1116
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-10,000
Closed -$180K
BBBY
1117
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
-40,000
Closed -$424K
AUY
1118
CALL
DELISTED
Yamana Gold, Inc.
AUY
-30,000
Closed -$164K
CLVS
1119
DELISTED
Clovis Oncology, Inc.
CLVS
-5,500
Closed -$37K
CLVS
1120
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
-40,000
Closed -$270K
SWCH
1121
CALL
DELISTED
Switch, Inc. Class A Common Stock
SWCH
-103,700
Closed -$1.85M
ZEN
1122
DELISTED
ZENDESK INC
ZEN
-7,000
Closed -$655K
GBT
1123
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
-47,000
Closed -$2.97M
ZNGA
1124
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-22,500
Closed -$215K
ARNA
1125
DELISTED
Arena Pharmaceuticals Inc
ARNA
-18,500
Closed -$1.23M

Similar funds

SG3 Management's Q3 2020 Portfolio in Review

As of Q3 2020, SG3 Management held 1,149 positions worth $2.7B, up 87% from $1.45B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

SG3 Management deployed $1B of net new capital in Q3 2020, opening 553 new positions and adding to 136 existing holdings. Its largest new stake was Alphabet (Google) Class A: 242,000 shares worth $17.7M.

By sector, the portfolio is most concentrated in Technology at 1.4% of assets, up from 1% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Sea Limited, an estimated $23.8M trimmed.

  • SG3 Management's largest Q3 2020 buy was Alphabet (Google) Class A: 242,000 shares worth $17.7M.
  • SG3 Management added most to Beyond Meat in Q3 2020, an estimated $6.3M increase.
  • SG3 Management's biggest Q3 2020 reduction was Sea Limited, cutting an estimated $23.8M.
  • SG3 Management fully exited Alibaba in Q3 2020, selling an estimated $8.56M.
  • SG3 Management's ten largest holdings make up 20% of its $2.7B portfolio in Q3 2020.
  • SG3 Management opened 553 new positions and closed 286 in Q3 2020.
  • SG3 Management's portfolio value rose 87% quarter-over-quarter to $2.7B.

Based on SG3 Management's 13F filing for Q3 2020, filed 13 Nov 2020.